Spectrum Science

🎉 We did it! 🎉 We’re beyond proud to announce that our Bristol Myers Squibb UK & Ireland Cancer Equals campaign picked up two wins at the PMEA Awards for… 🏆 Excellence in Public Health 🏆 Award for Patient Centricity This achievement wouldn’t have been possible without the incredible trust and collaboration from BMS, Shine Cancer Support and the people living with cancer who shared their stories and experiences with us. These awards are a testament to the strength of our long-standing partnership with BMS, allowing us to deliver such a powerful campaign that drives real impact. #WhereAbilityMeetsAgility is not just a tagline, it’s the way we work—and this award-winning campaign showcases exactly that. Our team has shown dedication to bring attention to the crucial issue of health inequalities. A massive thank you to everyone involved for their hard work, passion, and commitment. Together, we’re making a real difference! 💪 #HealthInequalities #CancerEquals #PMEAAwards2024 #Winner #WhereAbilityMeetsAgility

Three is the magic number! We’re beyond excited to share that Aurora Healthcare Communications has been shortlisted for three categories at the PMEA Awards 2024! ✨First, Aurora is in the running for PMEA Support Agency of the Year! Our vision is to deliver innovation, change lives, and make progress possible. This recognition reflects our commitment to delivering life-changing work by partnering with clients who share our bold vision. ✨Additionally, our impactful Cancer Equals campaign, developed in collaboration with Bristol Myers Squibb, has been shortlisted in the categories for Excellence in Public Health and Award for Patient Centricity. We owe a huge thank you to Bristol Myers Squibb UK & Ireland and Shine Cancer Support for trusting us with this important work by bringing attention to health inequalities in cancer. We’re thrilled to celebrate the innovative work shaping our industry at the PMEA Awards on 21 November. Good luck to all the nominees – see you there!🍀 #PMEA2024 #WhereAbilityMeetsAgility #HealthInequalities #CancerEquals

Returning from SCOPE Europe, Stephen O'Farrell and Neil Weisman reflect on the "significant value left unrealized" in the clinical trial process - especially as trial operations get more complex - and propose a better way forward.

If you're attending SCOPE Europe 2024, keep an eye out for Neil Weisman, President of Continuum Clinical, as he joins global leaders to explore cutting-edge innovations and shape the future of clinical trial operations.